476 related articles for article (PubMed ID: 30449449)
1. Structural and functional aspects of P-glycoprotein and its inhibitors.
Mollazadeh S; Sahebkar A; Hadizadeh F; Behravan J; Arabzadeh S
Life Sci; 2018 Dec; 214():118-123. PubMed ID: 30449449
[TBL] [Abstract][Full Text] [Related]
2. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
Waghray D; Zhang Q
J Med Chem; 2018 Jun; 61(12):5108-5121. PubMed ID: 29251920
[TBL] [Abstract][Full Text] [Related]
3. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
4. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
5. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
Chufan EE; Kapoor K; Ambudkar SV
Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resitance by natural substances from plants.
Molnár J; Engi H; Hohmann J; Molnár P; Deli J; Wesolowska O; Michalak K; Wang Q
Curr Top Med Chem; 2010; 10(17):1757-68. PubMed ID: 20645919
[TBL] [Abstract][Full Text] [Related]
7. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
8. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
[TBL] [Abstract][Full Text] [Related]
9. HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
Hu Z; Zhou Z; Hu Y; Wu J; Li Y; Huang W
PLoS One; 2015; 10(2):e0116886. PubMed ID: 25689592
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
Binkhathlan Z; Lavasanifar A
Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
[TBL] [Abstract][Full Text] [Related]
11. Marine natural products with P-glycoprotein inhibitor properties.
Lopez D; Martinez-Luis S
Mar Drugs; 2014 Jan; 12(1):525-46. PubMed ID: 24451193
[TBL] [Abstract][Full Text] [Related]
12. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M
Molecules; 2017 May; 22(6):. PubMed ID: 28587082
[TBL] [Abstract][Full Text] [Related]
13. Three decades of P-gp inhibitors: skimming through several generations and scaffolds.
Palmeira A; Sousa E; Vasconcelos MH; Pinto MM
Curr Med Chem; 2012; 19(13):1946-2025. PubMed ID: 22257057
[TBL] [Abstract][Full Text] [Related]
14. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
[TBL] [Abstract][Full Text] [Related]
16. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
[TBL] [Abstract][Full Text] [Related]
17. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
Bansal T; Jaggi M; Khar RK; Talegaonkar S
J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292
[TBL] [Abstract][Full Text] [Related]
18. Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide.
Janga KY; Tatke A; Shukla S; Lamichhane SP; Avula B; Wang X; Jablonski MM; Khan IA; Majumdar S
J Pharm Sci; 2018 Aug; 107(8):2128-2135. PubMed ID: 29678592
[TBL] [Abstract][Full Text] [Related]
19. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
Dinić J; Podolski-Renić A; Jeremić M; Pešić M
Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors.
Gao Y; Shi W; Cui J; Liu C; Bi X; Li Z; Huang W; Wang G; Qian H
Bioorg Med Chem; 2018 May; 26(9):2420-2427. PubMed ID: 29631786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]